Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

Completed

• Conditions: Asthma
• Interventions: Drug: Ciclesonide

• Registration Number: NCT00608218
• Lead Sponsor: AstraZeneca

Brief Summary

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Study First Submitted: 2008-01-23
• Study First Submitted QC: 2008-01-23
• Study First Posted: 2008-02-06
• Primary Completion: 2008-08
• Study Completion: 2008-08
• Status Verified: 2016-09
• Last Update Submitted: 2016-12-02
• Last Update Posted: 2016-12-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2100

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Artist	Ciclesonide	-

Primary Outcome Measures

Name	Time	Method
FEV1, symptom score assessment	within 3 months

Secondary Outcome Measures

Name	Time	Method
Handling of the metered-dose inhaler, safety and tolerability	within 3 months

Trial Locations

Locations (1)

"Nycomed Deutschland GmbH"; 🇩🇪 Würzburg, Germany